Fanconi anemia and novel strategies for therapy.
Liu
J M
JM
Hematology Branch, NHLBI, National Institutes of Health, Bethesda, MD 20892.
Buchwald
M
M
Walsh
C E
CE
Young
N S
NS
D000818:Animals; D016026:Bone Marrow Transplantation; D002453:Cell Cycle; D018797:Cell Cycle Proteins; D002478:Cells, Cultured; D002648:Child; D002675:Child, Preschool; D002899:Chromosomes, Human, Pair 9; D002986:Clinical Trials as Topic; D003001:Cloning, Molecular; D006224:Cricetinae; D003432:Cross-Linking Reagents / Q000494:pharmacology; D004260:DNA Repair; D004268:DNA-Binding Proteins; D004195:Disease Models, Animal; D005199:Fanconi Anemia / Q000235:genetics / Q000628:therapy*; D051856:Fanconi Anemia Complementation Group Proteins; D005796:Genes; D015316:Genetic Therapy; D006410:Hematopoiesis; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D051379:Mice; D009687:Nuclear Proteins; D011506:Proteins / Q000235:genetics / Q000502:physiology
D018797:Cell Cycle Proteins; D003432:Cross-Linking Reagents; D004268:DNA-Binding Proteins; D051856:Fanconi Anemia Complementation Group Proteins; D016298:Hematopoietic Cell Growth Factors; D009687:Nuclear Proteins; D011506:Proteins